Dr. Xiaorong He, Ph.D., MBA is Senior Vice President, Head of Global Development Sciences and U.S. Site Head of Non-Clinical Development at Boehringer Ingelheim Pharmaceuticals, Inc. ( https://www.boehringer-ingelheim.com/us ), where with over two decades of experience, her leadership focus lies in advancing transformative medicinal product development and fostering a culture of scientific excellence and engagement across her teams.
Prior to this role, Dr. He was VP and Head of the Material & Analytical Sciences Department at Boehringer Ingelheim, leading a large team of multidisciplinary scientists to develop and apply scientific methods and tools to support new drug development of chemical and biological entities.
Dr. He has previously worked for several large pharmaceutical companies, including Pfizer, GSK, Pharmacia & Upjohn before joining Boehringer Ingelheim. She received her Pharmacy B.S. degree from Beijing Medical University, M.S. degree in Pharmaceutics from University of Minnesota, Ph.D. degree in Pharmaceutics from Purdue University and M.B.A. degree from Western Michigan University.
Dr. He has also taught several short courses, given numerous podium presentations at national and international conferences, published many peer-reviewed papers and book chapters, and held several patents. She has been a member of scientific and editorial advisory boards for the Journal of Pharmaceutical Sciences since 2013.
Dr. He has also been volunteering with organizations such as the United States Pharmacopeia (USP) since 2005, first with the Excipient Monograph Expert Committee (2005-2010), then with the General Chapter-Physical Analysis Expert Committee (2010-2015). She has served as the Chair of the General Chapters–Physical Analysis Expert Committee during the 2015–2020 cycle.
Boehringer Ingelheim Open Innovation Portal - https://www.opnme.com/
Dr. Xiaorong He, Ph.D., MBA is Senior Vice President, Head of Global Development Sciences and U.S. Site Head of Non-Clinical Development at Boehringer Ingelheim Pharmaceuticals, Inc. ( https://www.boehringer-ingelheim.com/us ), where with over two decades of experience, her leadership focus lies in advancing transformative medicinal product development and fostering a culture of scientific excellence and engagement across her teams.
Prior to this role, Dr. He was VP and Head of the Material & Analytical Sciences Department at Boehringer Ingelheim, leading a large team of multidisciplinary scientists to develop and apply scientific methods and tools to support new drug development of chemical and biological entities.
Dr. He has previously worked for several large pharmaceutical companies, including Pfizer, GSK, Pharmacia & Upjohn before joining Boehringer Ingelheim. She received her Pharmacy B.S. degree from Beijing Medical University, M.S. degree in Pharmaceutics from University of Minnesota, Ph.D. degree in Pharmaceutics from Purdue University and M.B.A. degree from Western Michigan University.
Dr. He has also taught several short courses, given numerous podium presentations at national and international conferences, published many peer-reviewed papers and book chapters, and held several patents. She has been a member of scientific and editorial advisory boards for the Journal of Pharmaceutical Sciences since 2013.
Dr. He has also been volunteering with organizations such as the United States Pharmacopeia (USP) since 2005, first with the Excipient Monograph Expert Committee (2005-2010), then with the General Chapter-Physical Analysis Expert Committee (2010-2015). She has served as the Chair of the General Chapters–Physical Analysis Expert Committee during the 2015–2020 cycle.
Boehringer Ingelheim Open Innovation Portal - https://www.opnme.com/